We are live on ! Find out more

Small Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
SRPT icon
1
Sarepta Therapeutics
SRPT
$1.98B
$1.98B $18.79 2.24%
TSHA icon
2
Taysha Gene Therapies
TSHA
$1.98B
$1.98B $6.09 0.33%
AGIO icon
3
Agios Pharmaceuticals
AGIO
$1.98B
$1.98B $33.09 1.61%
KARD
4
Kardigan Inc
KARD
$1.97B
$1.97B $21.02 3.75%
GHRS icon
5
GH Research
GHRS
$1.94B
$1.94B $28.33 1.22%
DMRA
6
Damora Therapeutics
DMRA
$1.9B
$1.9B $30.82 1.68%
IMCR icon
7
Immunocore
IMCR
$1.9B
$1.9B $36.88 1.65%
LKFT
8
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
$1.89B $28.80 1.87%
RXRX icon
9
Recursion Pharmaceuticals
RXRX
$1.88B
$1.88B $3.50 4.79%
SEPN
10
Septerna Inc
SEPN
$1.87B
$1.87B $40 1.94%
NTLA icon
11
Intellia Therapeutics
NTLA
$1.8B
$1.8B $12.84 3.22%
SNDX icon
12
Syndax Pharmaceuticals
SNDX
$1.75B
$1.75B $19.65 0.51%
FTRE icon
13
Fortrea Holdings
FTRE
$1.75B
$1.75B $18.39 1.1%
ANAB icon
14
AnaptysBio
ANAB
$1.71B
$1.71B $57.74 1.85%
AVLN
15
Avalyn Pharma
AVLN
$1.7B
$1.7B $38.37 3.34%
VIR icon
16
Vir Biotechnology
VIR
$1.65B
$1.65B $9.78 6.19%
ABSI icon
17
Absci
ABSI
$1.64B
$1.64B $9.55 2.91%
MAZE
18
Maze Therapeutics
MAZE
$1.63B
$1.63B $29.43 1.73%
FBRX icon
19
Forte Biosciences
FBRX
$1.63B
$1.63B $76.92 0.04%
AAPG
20
Ascentage Pharma
AAPG
$1.59B
$1.59B $17 1.85%
BCAX
21
Bicara Therapeutics
BCAX
$1.58B
$1.58B $23.90 2.01%
TYRA icon
22
Tyra Biosciences
TYRA
$1.55B
$1.55B $26.05 1.4%
TRAX
23
First Tracks Biotherapeutics
TRAX
$1.54B
$1.54B $43.11 2.89%
LBRX
24
LB Pharmaceuticals
LBRX
$1.54B
$1.54B $47.62 0.83%
INBX icon
25
Inhibrx
INBX
$1.53B
$1.53B $103.63 4.52%
1
2 3 4 5

Small Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 191 small cap Biotechnology stocks — companies in the Biotechnology industry with a market cap between $250M and $2B — worth a combined $158B.

The largest by market cap are Sarepta Therapeutics (SRPT) at $1.98B, Taysha Gene Therapies (TSHA) at $1.98B and Agios Pharmaceuticals (AGIO) at $1.98B.

Among institutional investors, First Tracks Biotherapeutics (TRAX) drew the most net new fund positions in Q2 2026: 147 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.